Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 2015

View Archived Issues

NINDS to study Thrombolytic Science's dual thrombolytic therapy for acute ischemic stroke

Astellas and Anokion form Kanyos to develop autoimmune disease therapies

NCCN and Pfizer establish grant program to improve patient care in metastatic breast cancer

Novo Nordisk introduces human PYY analogues

Business collaboration agreement signed betwwen JCR Pharma and Shin Nippon

Sigma-Aldrich to sell Xcell Science's neural cells as research tools

Protein disulfide isomerase inhibitors may be used to treat chikungunya virus infection

Sustained responses seen with LY-2951742 in migraineurs

Genmab licenses antibodies targeting CD19 from Bristol-Myers Squibb

Interim phase II pediatric data on KRN-23 for X-linked hypophosphatemia lead to trial expansion

Weill Cornell Medical College and Cellectis enter strategic translational research alliance in AML

ONO-2952, a TSPO antagonist for IBS-D: RESTORE-4 phase II clinical results

Pronutria to use KineMed's proteomics platform to evaluate biologics for amino acid homeostasis

Vectura initiates phase I trial of asthma candidate VR-942

FDA grants orphan drug designation to APTO-253 for AML

Stempeucel gets E.U. orphan drug designation

ABT-414 shows potential for the treatment of solid tumors

FDA clears IND for phase II trial of ADXS-HPV and epacadostat in cervical cancer

Emergent BioSolutions uses ProBioGen's duck cell line to produce clinical supplies of MVA-EBOZ

Bristol-Myers Squibb discloses CK1 inhibitors

KAEL-GemVax announces TNF-alpha production inhibitors

ViroCura patents HCV NS3/4A inhibitors

Sysmex and LabCorp form strategic collaboration to advance precision medicine for cancer

Midatech Pharma proposes to acquire DARA BioSciences

Regulus Therapeutics starts phase I trial of Alport syndrome candidate RG-012

Fast track designation for RE-024 in pantothenate kinase-associated neurodegeneration

FDA advisory committee recommends approval of Addyi for HSDD

Biogen files MAA for Alprolix for hemophilia B

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...